Argos Therapeutics, Inc. Plans to Reduce its Workforce by 18 Employees; Announces the Resignation of Fred Miesowicz as Chief Operating Officer, with Effect from April 22, 2016
In addition, on April 15, 2016, Fred Miesowicz, the company's Chief Operating Officer, notified the company of his intention to resign from that position effective as of April 22, 2016. The company expects to enter into a consulting arrangement with Dr. Miesowicz that will continue through mid-2017, when Dr. Miesowicz expects to retire. However, the terms of his engagement have not been finalized.